Search

Your search keyword '"Leiter, Lawrence A."' showing total 1,122 results

Search Constraints

Start Over You searched for: Author "Leiter, Lawrence A." Remove constraint Author: "Leiter, Lawrence A." Search Limiters Full Text Remove constraint Search Limiters: Full Text
1,122 results on '"Leiter, Lawrence A."'

Search Results

2. A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings

4. Prevention and Management of Cardiovascular Disease in Primary Care: A Comment on the PEER Simplified Lipid Guideline

8. Effect of Sotagliflozin on Early Mortality and Heart Failure-Related Events: A Post Hoc Analysis of SOLOIST-WHF

9. Important food sources of fructose-containing sugars and adiposity: A systematic review and meta-analysis of controlled feeding trials

10. Use of non‐LDL‐C lipid‐lowering medications in patients with type 2 diabetes

12. Low-carbohydrate vegan diets in diabetes for weight loss and sustainability: a randomized controlled trial

13. Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes: A FIDELITY Subgroup Analysis

15. A novel kidney disease index reflecting both the albumin-to-creatinine ratio and estimated glomerular filtration rate, predicted cardiovascular and kidney outcomes in type 2 diabetes

16. Empagliflozin and Left Ventricular Remodeling in People Without Diabetes: Primary Results of the EMPA-HEART 2 CardioLink-7 Randomized Clinical Trial

17. Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract

18. A randomized trial of icosapent ethyl in ambulatory patients with COVID-19

24. Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

27. Natriuretic Peptides, Body Mass Index and Heart Failure Risk: Pooled Analyses of SAVOR‐TIMI 53, DECLARE‐TIMI 58 and CAMELLIA‐TIMI 61

31. Effects of dapagliflozin on hospitalisations in people with type 2 diabetes: post-hoc analyses of the DECLARE-TIMI 58 trial

32. Natriuretic peptides, body mass index and heart failure risk: Pooled analyses of SAVOR‐TIMI 53, DECLARE‐TIMI 58 and CAMELLIA‐TIMI 61.

33. Fructose-containing food sources and blood pressure: A systematic review and meta-analysis of controlled feeding trials

34. P22-010-23 Coronary Heart Effectiveness Assessment of the Portfolio Diet in Primary Care (CHEAP) Trial: Protocol for a Randomized Controlled Trial

35. P24-046-23 Substitution of Sweetened Soymilk for Unsweetened Cow's Milk and Cardiometabolic Health: A Systematic Review and Meta-Analysis of Randomized Controlled Feeding Trials

38. Time to clinical benefit with sotagliflozin in patients with type 2 diabetes and chronic kidney disease: Insights from the SCORED randomized trial.

39. Total cardiovascular or fatal events in people with type 2 diabetes and cardiovascular risk factors treated with dulaglutide in the REWIND trail: a post hoc analysis

45. Abstract 16139: A Targeted Proteomic Approach to Identify Circulating Biomarkers of Heart Failure Risk in Patients With Type 2 Diabetes Mellitus in DECLARE-TIMI 58

46. Abstract 15701: Relationship Between Cardiac Biomarkers and Major Adverse Cardiovascular Events in DECLARE-TIMI 58

Catalog

Books, media, physical & digital resources